These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23871676)

  • 1. Usefulness of losartan on the size of the ascending aorta in an unselected cohort of children, adolescents, and young adults with Marfan syndrome.
    Pees C; Laccone F; Hagl M; Debrauwer V; Moser E; Michel-Behnke I
    Am J Cardiol; 2013 Nov; 112(9):1477-83. PubMed ID: 23871676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ghent Marfan Trial--a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with β-blockers.
    Möberg K; De Nobele S; Devos D; Goetghebeur E; Segers P; Trachet B; Vervaet C; Renard M; Coucke P; Loeys B; De Paepe A; De Backer J
    Int J Cardiol; 2012 Jun; 157(3):354-8. PubMed ID: 21239069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Losartan added to β-blockade therapy for aortic root dilation in Marfan syndrome: a randomized, open-label pilot study.
    Chiu HH; Wu MH; Wang JK; Lu CW; Chiu SN; Chen CA; Lin MT; Hu FC
    Mayo Clin Proc; 2013 Mar; 88(3):271-6. PubMed ID: 23321647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of losartan vs. atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial.
    Forteza A; Evangelista A; Sánchez V; Teixidó-Turà G; Sanz P; Gutiérrez L; Gracia T; Centeno J; Rodríguez-Palomares J; Rufilanchas JJ; Cortina J; Ferreira-González I; García-Dorado D
    Eur Heart J; 2016 Mar; 37(12):978-85. PubMed ID: 26518245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.
    Groenink M; den Hartog AW; Franken R; Radonic T; de Waard V; Timmermans J; Scholte AJ; van den Berg MP; Spijkerboer AM; Marquering HA; Zwinderman AH; Mulder BJ
    Eur Heart J; 2013 Dec; 34(45):3491-500. PubMed ID: 23999449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Aortic root dilatation rate in pediatric patients with Marfan syndrome treated with losartan].
    Mariucci E; Guidarini M; Donti A; Lovato L; Wischmeijer A; Angeli E; Gargiulo GD; Picchio FM; Bonvicini M
    G Ital Cardiol (Rome); 2015 Dec; 16(12):690-5. PubMed ID: 26667946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Rapid Aortic Root Dilation and Referral for Aortic Surgery in Marfan Syndrome.
    Hoskoppal A; Menon S; Trachtenberg F; Burns KM; De Backer J; Gelb BD; Gleason M; James J; Lai WW; Liou A; Mahony L; Olson AK; Pyeritz RE; Sharkey AM; Stylianou M; Wechsler SB; Young L; Levine JC; Tierney ESS; Lacro RV; Bradley TJ;
    Pediatr Cardiol; 2018 Oct; 39(7):1453-1461. PubMed ID: 29948025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marfan Sartan: a randomized, double-blind, placebo-controlled trial.
    Milleron O; Arnoult F; Ropers J; Aegerter P; Detaint D; Delorme G; Attias D; Tubach F; Dupuis-Girod S; Plauchu H; Barthelet M; Sassolas F; Pangaud N; Naudion S; Thomas-Chabaneix J; Dulac Y; Edouard T; Wolf JE; Faivre L; Odent S; Basquin A; Habib G; Collignon P; Boileau C; Jondeau G
    Eur Heart J; 2015 Aug; 36(32):2160-6. PubMed ID: 25935877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.
    Yang HH; Kim JM; Chum E; van Breemen C; Chung AW
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):305-312.e2. PubMed ID: 20189193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of losartan as add-on therapy to prevent aortic growth and ventricular dysfunction in patients with Marfan syndrome: a randomized, double-blind clinical trial.
    Muiño-Mosquera L; De Nobele S; Devos D; Campens L; De Paepe A; De Backer J
    Acta Cardiol; 2017 Dec; 72(6):616-624. PubMed ID: 28657492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized, double blind pilot study to assess the effects of losartan vs. atenolol on the biophysical properties of the aorta in patients with Marfan and Loeys-Dietz syndromes.
    Sandor GG; Alghamdi MH; Raffin LA; Potts MT; Williams LD; Potts JE; Kiess M; van Breemen C
    Int J Cardiol; 2015 Jan; 179():470-5. PubMed ID: 25465809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome.
    Valdivia Callejon I; Buccioli L; Bastianen J; Schippers J; Verstraeten A; Luyckx I; Peeters S; Danser AHJ; Van Kimmenade RRJ; Meester J; Loeys B
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimorphic effects of transforming growth factor-β signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome.
    Cook JR; Clayton NP; Carta L; Galatioto J; Chiu E; Smaldone S; Nelson CA; Cheng SH; Wentworth BM; Ramirez F
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):911-7. PubMed ID: 25614286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy.
    Lacro RV; Guey LT; Dietz HC; Pearson GD; Yetman AT; Gelb BD; Loeys BL; Benson DW; Bradley TJ; De Backer J; Forbus GA; Klein GL; Lai WW; Levine JC; Lewin MB; Markham LW; Paridon SM; Pierpont ME; Radojewski E; Selamet Tierney ES; Sharkey AM; Wechsler SB; Mahony L;
    Am Heart J; 2013 May; 165(5):828-835.e3. PubMed ID: 23622922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
    Brooke BS; Habashi JP; Judge DP; Patel N; Loeys B; Dietz HC
    N Engl J Med; 2008 Jun; 358(26):2787-95. PubMed ID: 18579813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype.
    De Backer J
    Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dilation of peripheral vessels in Marfan syndrome: importance of thoracoabdominal MR angiography.
    Mariucci EM; Lovato L; Rosati M; Palena LM; Bonvicini M; Fattori R
    Int J Cardiol; 2013 Sep; 167(6):2928-31. PubMed ID: 22954416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased Aortic Elasticity in Children With Marfan Syndrome or Loeys-Dietz Syndrome.
    Akazawa Y; Motoki N; Tada A; Yamazaki S; Hachiya A; Matsuzaki S; Kamiya M; Nakamura T; Kosho T; Inaba Y
    Circ J; 2016 Oct; 80(11):2369-2375. PubMed ID: 27733734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome.
    Selamet Tierney ES; Levine JC; Sleeper LA; Roman MJ; Bradley TJ; Colan SD; Chen S; Campbell MJ; Cohen MS; De Backer J; Heydarian H; Hoskoppal A; Lai WW; Liou A; Marcus E; Nutting A; Olson AK; Parra DA; Pearson GD; Pierpont ME; Printz BF; Pyeritz RE; Ravekes W; Sharkey AM; Srivastava S; Young L; Lacro RV;
    Am J Cardiol; 2018 May; 121(9):1094-1101. PubMed ID: 29631804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losartan Versus Atenolol for Prevention of Aortic Dilation in Patients With Marfan Syndrome.
    Teixido-Tura G; Forteza A; Rodríguez-Palomares J; González Mirelis J; Gutiérrez L; Sánchez V; Ibáñez B; García-Dorado D; Evangelista A
    J Am Coll Cardiol; 2018 Oct; 72(14):1613-1618. PubMed ID: 30261963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.